FR116M - New sulfonamide derivative usable in therapy. - Google Patents

New sulfonamide derivative usable in therapy.

Info

Publication number
FR116M
FR116M FR835239A FR835239A FR116M FR 116 M FR116 M FR 116M FR 835239 A FR835239 A FR 835239A FR 835239 A FR835239 A FR 835239A FR 116 M FR116 M FR 116M
Authority
FR
France
Prior art keywords
therapy
sulfonamide derivative
derivative usable
new sulfonamide
usable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR835239A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR791877A external-priority patent/FR1281222A/en
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Priority to FR835239A priority Critical patent/FR116M/en
Application granted granted Critical
Publication of FR116M publication Critical patent/FR116M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/42—Benzene-sulfonamido pyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR835239A 1958-04-23 1960-08-08 New sulfonamide derivative usable in therapy. Active FR116M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR835239A FR116M (en) 1958-04-23 1960-08-08 New sulfonamide derivative usable in therapy.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH5866158A CH366546A (en) 1958-04-23 1958-04-23 Process for the preparation of methylene-5- (p-aminobenzenesulfonylamido) -1-phenyl-pyrazole
FR791877A FR1281222A (en) 1959-04-13 1959-04-13 Process for preparing nu, nu'-methylene-bis-3- (p-amino-benzenesulfonamido) -2-phenyl-pyrazole
FR835239A FR116M (en) 1958-04-23 1960-08-08 New sulfonamide derivative usable in therapy.

Publications (1)

Publication Number Publication Date
FR116M true FR116M (en) 1961-01-09

Family

ID=4521837

Family Applications (1)

Application Number Title Priority Date Filing Date
FR835239A Active FR116M (en) 1958-04-23 1960-08-08 New sulfonamide derivative usable in therapy.

Country Status (3)

Country Link
CH (1) CH366546A (en)
ES (1) ES248157A1 (en)
FR (1) FR116M (en)

Also Published As

Publication number Publication date
CH366546A (en) 1963-01-15
ES248157A1 (en) 1960-04-16

Similar Documents

Publication Publication Date Title
FR302M (en) New m-butoxy-phenoxy-ethylamine usable in therapy.
FR308M (en) New pyridyl-ethyl-guanidine usable in therapy.
FR116M (en) New sulfonamide derivative usable in therapy.
FR115M (en) New sulfonamide usable in therapy.
FR164M (en) New hydrazine usable in therapy.
FR1225437A (en) Eyelid
FR1898M (en) New substance usable in therapy.
BE581628A (en) Stretcher-twist.
FR353M (en) New quinoline usable in therapy.
FR163M (en) New phenoxy-ethylamine usable in therapy.
FR221M (en) New guanidine usable in therapy.
FR350M (en) New antibiotic lankavamycin usable in therapy.
FR349M (en) New 1,3-dihydroxy-2-nitro-tricos-4-yne usable in therapy.
FR309M (en) New piperazino-ethyl-guanidine usable in therapy.
FR1216476A (en) Gantry
DK106453C (en) Endoradiosonde.
FR351M (en) New antibiotic lankavacidin usable in therapy.
FR352M (en) New ferrimycin antibiotic usable in therapy.
FR348M (en) New 3,5,6-substituted glucofuranoside usable in therapy.
FR1217838A (en) Piggy bank
ES63919Y (en) Piggy bank
BE596272A (en) New substance usable in therapy.
FR1029M (en) New 17α-isobutyl-androstane-3β, 17β-diol usable in therapy.
BE583856A (en) Opacifying agent usable in readiology.
FI29893A (en) Svällbara, syrafasta vattenglaskitt